Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas

Published:2015-12-12 Issue:3 Volume:52 Page:641-651
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Cai Lin,Leng Zhi Gen,Guo Yu Hang,Lin Shao Jian,Wu Ze Rui,Su Zhi Peng,Lu Jiang Long,Wei Li Fei,Zhuge Qi Chuan,Jin Kunlin,Wu Zhe Bao

Funder

National Natural Science Foundation of China (CN)

Zhejiang Open Foundation of the Top Key Discipline

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s12020-015-0824-2.pdf

Reference59 articles.

1. M.P. Gillam, M.E. Molitch, G. Lombardi, A. Colao, Advances in the treatment of prolactinomas. Endocr. Rev. 27(5), 485–534 (2006)

2. Z.B. Wu, C.J. Yu, Z.P. Su, Q.C. Zhuge, J.S. Wu, W.M. Zheng, Bromocriptine treatment of invasive giant prolactinomas involving the cavernous sinus: results of a long-term follow up. J. Neurosurg. 104(1), 54–61 (2006)

3. F.F. Casanueva, M.E. Molitch, J.A. Schlechte, R. Abs, V. Bonert, M.D. Bronstein, T. Brue, P. Cappabianca, A. Colao, R. Fahlbusch, H. Fideleff, M. Hadani, P. Kelly, D. Kleinberg, E. Laws, J. Marek, M. Scanlon, L.G. Sobrinho, J.A. Wass, A. Giustina, Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin. Endocrinol. (Oxf) 65(2), 265–273 (2006)

4. S. Melmed, F.F. Casanueva, A.R. Hoffman, D.L. Kleinberg, V.M. Montori, J.A. Schlechte, J.A. Wass, Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96(2), 273–288 (2011)

5. A. Colao, S. Savastano, Medical treatment of prolactinomas. Nat. Rev. Endocrinol. 7(5), 267–278 (2011)

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting ESM1 via SOX4 promotes the progression of infantile hemangioma through the PI3K/AKT signaling pathway;2024-05-30

2. Functional analysis of ESM1 by shRNA-mediated knockdown of its expression in papillary thyroid cancer cells;PLOS ONE;2024-04-16

3. Drug resistance mechanisms in dopamine agonist-resistant prolactin pituitary neuroendocrine tumors and exploration for new drugs;Drug Resistance Updates;2024-03

4. Roles of endothelial cell specific molecule‑1 in tumor angiogenesis (Review);Oncology Letters;2024-02-01

5. Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways;International Journal of Molecular Sciences;2023-10-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3